Çelik İ - Search Results

1

Detection of natural compounds by virtual screening, molecular docking and dynamics studies and evaluation of their effects on tau level in vitro Alzheimer's model.

Uzunhisarcıklı E, Çelik İ, Yerer MB. Uzunhisarcıklı E, et al. Among authors: celik i. J Biomol Struct Dyn. 2024 Jan-Feb;42(1):384-392. doi: 10.1080/07391102.2023.2192806. Epub 2023 Mar 22. J Biomol Struct Dyn. 2024. PMID: 36946204

2

Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach.

Khairy A, Hammoda HM, Celik I, Zaatout HH, Ibrahim RS. Khairy A, et al. Among authors: celik i. Sci Rep. 2022 Nov 9;12(1):19037. doi: 10.1038/s41598-022-23006-1. Sci Rep. 2022. PMID: 36351991 Free PMC article.

3

Exploring the structural, photophysical and optoelectronic properties of a diaryl heptanoid curcumin derivative and identification as a SARS-CoV-2 inhibitor.

Archana VP, Armaković SJ, Armaković S, Celik I, Bhagyasree JB, Dinesh Babu KV, Rudrapal M, Divya IS, Pillai RR. Archana VP, et al. Among authors: celik i. J Mol Struct. 2023 Jun 5;1281:135110. doi: 10.1016/j.molstruc.2023.135110. Epub 2023 Feb 9. J Mol Struct. 2023. PMID: 36785704 Free PMC article.

4

The depsidones from marine sponge-derived fungus Aspergillus unguis IB151 as an anti-MRSA agent: Molecular docking, pharmacokinetics analysis, and molecular dynamic simulation studies.

Handayani D, Aminah I, Pontana Putra P, Eka Putra A, Arbain D, Satriawan H, Efdi M, Celik I, Ekawati Tallei T. Handayani D, et al. Among authors: celik i. Saudi Pharm J. 2023 Sep;31(9):101744. doi: 10.1016/j.jsps.2023.101744. Epub 2023 Aug 9. Saudi Pharm J. 2023. PMID: 37649676 Free PMC article.

5

Molecular insights into the anti-inflammatory activity of fermented pineapple juice using multimodal computational studies.

Tallei TE, Fatimawali, Adam AA, Ekatanti D, Celik I, Fatriani R, Nainu F, Kusuma WA, Rabaan AA, Idroes R. Tallei TE, et al. Among authors: celik i. Arch Pharm (Weinheim). 2024 Jan;357(1):e2300422. doi: 10.1002/ardp.202300422. Epub 2023 Oct 20. Arch Pharm (Weinheim). 2024. PMID: 37861276

6

Interaction mechanism of a pesticide, Azoxystrobin with bovine serum albumin: Assessments through fluorescence, UV-Vis absorption, electrochemical and molecular docking simulation techniques.

Erkmen C, Celik I. Erkmen C, et al. Among authors: celik i. Spectrochim Acta A Mol Biomol Spectrosc. 2024 Mar 5;308:123719. doi: 10.1016/j.saa.2023.123719. Epub 2023 Dec 5. Spectrochim Acta A Mol Biomol Spectrosc. 2024. PMID: 38064964

7

Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in silico and in vitro combination analysis.

Nada AA, Metwally AM, Asaad AM, Celik I, Ibrahim RS, Eldin SMS. Nada AA, et al. Among authors: celik i. BMC Complement Med Ther. 2024 Jan 30;24(1):65. doi: 10.1186/s12906-024-04348-x. BMC Complement Med Ther. 2024. PMID: 38291462 Free PMC article.

8

Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies.

Doganc F, Ozkan T, Farhangzad N, Mavideniz A, Celik I, Sunguroglu A, Göker H. Doganc F, et al. Among authors: celik i. Bioorg Chem. 2024 May 5;148:107429. doi: 10.1016/j.bioorg.2024.107429. Online ahead of print. Bioorg Chem. 2024. PMID: 38728910

9

Identification and in-vitro analysis of potential proteasome inhibitors targeting PSMβ5 for multiple myeloma.

Yadav R, Nath UK, Celik I, Handu S, Jain N, Dhamija P. Yadav R, et al. Among authors: celik i. Biomed Pharmacother. 2023 Jan;157:113963. doi: 10.1016/j.biopha.2022.113963. Epub 2022 Nov 15. Biomed Pharmacother. 2023. PMID: 36399828 Free article.

10

Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation.

Bender O, Shoman ME, Ali TFS, Dogan R, Celik I, Mollica A, Hamed MIA, Aly OM, Alamri A, Alanazi J, Ahemad N, Gan SH, Malik JA, Anwar S, Atalay A, Beshr EAM. Bender O, et al. Among authors: celik i. Arch Pharm (Weinheim). 2023 Feb;356(2):e2200407. doi: 10.1002/ardp.202200407. Epub 2022 Nov 20. Arch Pharm (Weinheim). 2023. PMID: 36403191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

694 results

Search Page